SCHEMBL370074

SCHEMBL370074

O=C(O)c1cc(-c2cccnc2)no1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 1/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2B6 P20813 1/20 0.55
CYP2C19 P33261 1/20 0.55
NAMPT P43490 1/20 0.55
PIM1 P11309 1/20 0.52
PIM2 Q9P1W9 1/20 0.52
KMO O15229 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 2/20 0.51
MKNK1 Q9BUB5 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
BRAF P15056 1/20 0.50
USP30 Q70CQ3 1/20 0.49
PTPN1 P18031 2/20 0.49
TP53 P04637 2/20 0.47
CYP19A1 P11511 1/20 0.47
IP6K1 Q92551 1/20 0.47
IP6K3 Q96PC2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516614 1.00 CYP2E1 (0.55) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL30516607 0.86 CYP2E1 (0.57) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL23930645 0.86 CYP2A6 (0.54) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL6872027 0.86 CYP2E1 (0.57) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL368446 0.86 CYP2C9 (0.54) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL212382 0.84 RAB9A (0.68) CYP2C9CYP2C19SMN1; SMN2RAB9APTPN1
SCHEMBL11509604 0.83 RAB9A (0.57) KMOSMN1; SMN2RAB9APTPN1ALDH1A1
Hydrochloric Acid SCHEMBL8880218 0.83 RAB9A (0.66) CYP2C9CYP2C19SMN1; SMN2RAB9APTPN1
SCHEMBL30516592 0.82 CYP19A1 (0.51) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL23930576 0.82 CYP2C9 (0.54) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
CN-103140483-B Novel heterocyclic compounds as pesticides BAYER CROPSCIENCE AG 2015-06-24 CN disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
CN-104086528-A Novel heterocyclic compounds as pesticides BAYER IP GMBH 2014-10-08 CN disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
CN-103140483-A novel heterocyclic compounds as pesticides BAYER CROPSCIENCE AG 2013-06-05 CN disclosed
EP-2593447-A2 NEW HETEROCYCLIC COMPOUNDS AS PESTICIDES Bayer Intellectual Property GmbH (DE) 2013-05-22 EP disclosed
WO-2012007500-A2 NEW HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-01-19 WO disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
WO-2010053162-A1 NON-AQUEOUS ELECTROLYSIS SOLUTION CONTAINING PYRIDYL 5-MEMBERED HETEROCYCLIC DERIVATIVE, AND LITHIUM SECONDARY BATTERY 三井化学株式会社 (JP) 2010-05-14 WO disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 CYP2E1 203/4885CYP2A6 572/4885CYP2C9 915/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT CYP2E1 130/4885CYP2A6 378/4885CYP2C9 608/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 CYP2E1 187/4885CYP2A6 276/4885CYP2C9 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.